BACKGROUND
Allogeneic hematopoietic stem cell transplantation (HSCT) is a curative therapy for refractory hematologic diseases, but its success is often limited by life-threatening, endothelial injury-related complications such as sinusoidal obstruction syndrome (SOS) and transplant-associated thrombotic microangiopath...
Takayuki Yokokawa, Masahiko Fukatsu, K. Fukuchi et al.· Immunobiology· 0 citations
T follicular helper cell lymphomas (TFHL) harbor activating T cell receptor (TCR) signaling mutations and epigenetic alterations, such as TET2 mutations. Here, we conduct a multi-center, single-arm, phase 2 trial of the tyrosine kinase inhibitor dasatinib in patients with relapsed/refractory TFHLs (jRCT2031190079). The...
S. Suma, M. Sakata-Yanagimoto, Y. Suehara et al.· Nature Communications· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.